APVEL - Evaluation of the effectiveness of specialized outpatient palliative care (SAPV) in North Rhine

APVEL - Evaluation of the effectiveness of specialized outpatient palliative care (SAPV) in North Rhine - APVEL

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00014748

Enrollment

256

Registered

2018-06-06

Start date

2017-12-29

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with advanced incurable diseases

Interventions

Group 1: SAPV patients in urban provision areas are questioned quantitatively at T0 by means of IPOS / Facit-Pal-14 and qualitatively with a semi-structured interview guide at their homes

at T1 (after 5 days) only the quantitative part is collected again by telephone contact

as well on T2 and T3 after each 5 days. Group 2: SAPV patients in rural provision areas are questioned quantitatively at T0 by means of IPOS / Facit-Pal-14 and qualitatively with a semi-structured int

as well on T2 and T3 after each 5 days. Group 3: AAPV patients in urban provision areas are questioned quantitatively at T0 by means of IPOS / Facit-Pal-14 and qualitatively with a semi-structured int

as well on T2 and T3 after each 5 days. Group 4: AAPV patients in rural provision areas are questioned quantitatively at T0 by means of IPOS / Facit-Pal-14 and qualitatively with a semi-structured int

as well on T2 and T3 after each 5 days. Group 5: general practitioners and oncologists in North Rhine are questioned by means of a questionnaire on the reasons for assignment to the different forms of

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Minimum age 18 years, patient with an incurable advanced tumor or non-tumor disease (e.g., neurological diseases or heart, lung, liver, kidney disease), ECOG 0-3, Prior informed consent and written consent of the patient or health care proxy / legal guardian, Patient receiving outpatient palliative care provision

Exclusion criteria

Exclusion criteria: Inability to give informed and written consent, Patient without a representative or legal guardian who can give consent for study participation, relation of dependency with the examiner

Design outcomes

Primary

Measure	Time frame
Efficacy comparison SAPV/AAPV: IPOS global sum score	—

Secondary

Measure	Time frame
Changes in Quality of Live: Facit -Pal-14	—

Countries

Germany

Contacts

Public ContactNorbert Krumm

Klinik für Palliativmedizin, Universitätsklinikum der RWTH Aachen

nkrumm@ukaachen.de0241 80 85719

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026